Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v5-EN
Language French English
Date Updated 2020-09-15 2020-09-15
Drug Identification Number 02330547 02330547
Brand name PIPERACILLIN SODIUM/TAZOBACTAM SODIUM POWDER FOR INJECTION PIPERACILLIN SODIUM/TAZOBACTAM SODIUM POWDER FOR INJECTION
Common or Proper name PIPERACILLIN SODIUM/TAZOBACTAM SODIUM POWDER FOR INJECTION PIPERACILLIN SODIUM/TAZOBACTAM SODIUM POWDER FOR INJECTION
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients PIPERACILLIN TAZOBACTAM PIPERACILLIN TAZOBACTAM
Strength(s) 12G 1.5G 12G 1.5G
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 1 PSOIJ CA 1 PSOIJ CA
ATC code J01CR J01CR
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Requirements related to complying with good manufacturing practices. Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2020-07-03 2020-07-03
Estimated end date 2020-08-31 2020-08-31
Actual end date 2020-09-11 2020-09-11
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments